IL161902A0 - Pharmaceutical formulation comprising bicalutamide - Google Patents
Pharmaceutical formulation comprising bicalutamideInfo
- Publication number
- IL161902A0 IL161902A0 IL16190202A IL16190202A IL161902A0 IL 161902 A0 IL161902 A0 IL 161902A0 IL 16190202 A IL16190202 A IL 16190202A IL 16190202 A IL16190202 A IL 16190202A IL 161902 A0 IL161902 A0 IL 161902A0
- Authority
- IL
- Israel
- Prior art keywords
- bicalutamide
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103839A SE0103839D0 (sv) | 2001-11-16 | 2001-11-16 | Pharmaceutical formulation & product |
| PCT/GB2002/005159 WO2003043606A1 (en) | 2001-11-16 | 2002-11-14 | Pharmaceutical formulation comprising bicalutamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161902A0 true IL161902A0 (en) | 2005-11-20 |
Family
ID=20286023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16190202A IL161902A0 (en) | 2001-11-16 | 2002-11-14 | Pharmaceutical formulation comprising bicalutamide |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20050038111A1 (sv) |
| EP (1) | EP1448168B1 (sv) |
| JP (1) | JP2005514355A (sv) |
| KR (1) | KR20050044468A (sv) |
| CN (1) | CN1615122A (sv) |
| AR (1) | AR037390A1 (sv) |
| AT (1) | ATE350016T1 (sv) |
| AU (1) | AU2002343024A1 (sv) |
| BR (1) | BR0214135A (sv) |
| CA (1) | CA2466986A1 (sv) |
| DE (1) | DE60217390T2 (sv) |
| ES (1) | ES2278063T3 (sv) |
| IL (1) | IL161902A0 (sv) |
| MX (1) | MXPA04004591A (sv) |
| NO (1) | NO20042502L (sv) |
| SE (1) | SE0103839D0 (sv) |
| TW (1) | TW200406200A (sv) |
| UY (1) | UY27539A1 (sv) |
| WO (1) | WO2003043606A1 (sv) |
| ZA (1) | ZA200403689B (sv) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20032225A3 (cs) * | 2001-02-27 | 2003-11-12 | Astrazeneca Ab | Farmaceutická formulace |
| US7524866B2 (en) | 2001-11-29 | 2009-04-28 | Gtx, Inc. | Prevention and treatment of androgen—deprivation induced osteoporosis |
| US7332525B2 (en) * | 2003-01-17 | 2008-02-19 | Castle Erik P | Method of treatment of prostate cancer and composition for treatment thereof |
| US7226622B2 (en) | 2003-09-18 | 2007-06-05 | Boston Scientific Scimed, Inc. | Chemoablation of tissue using biodegradable, solid salt dosage forms |
| WO2005072462A2 (en) * | 2004-01-28 | 2005-08-11 | Charles Shih | Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof |
| AU2005278894A1 (en) | 2004-08-31 | 2006-03-09 | Pfizer Products Inc. | Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
| GB0424339D0 (en) * | 2004-11-03 | 2004-12-08 | Astrazeneca Ab | Combination therapy |
| EP1954263A2 (en) * | 2005-02-23 | 2008-08-13 | AstraZeneca AB | Composition for increasing steady state plasma levels of bicalutamide |
| US20080177109A1 (en) * | 2005-03-29 | 2008-07-24 | Usv Limited | Novel Process for Preparation of Bicalutamide |
| US20090291134A1 (en) * | 2006-11-21 | 2009-11-26 | Jina Pharmaceuticals, Inc. | Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases |
| WO2009105264A1 (en) * | 2008-02-21 | 2009-08-27 | Iris International Inc. | Method for early determination of recurrence after therapy for prostate cancer |
| AU2009292615B2 (en) * | 2008-09-17 | 2015-12-03 | Mylan Inc. | Granulates, process for preparing them and pharmaceutical products containing them |
| EP3725778B1 (en) | 2012-09-11 | 2021-08-18 | Medivation Prostate Therapeutics LLC | Formulations of enzalutamide |
| CN107049972A (zh) * | 2017-03-17 | 2017-08-18 | 万特制药(海南)有限公司 | 一种含有来曲唑固体分散体的分散片及其制备工艺 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3121152A1 (de) * | 1981-05-22 | 1982-12-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie" |
| US4895715A (en) * | 1988-04-14 | 1990-01-23 | Schering Corporation | Method of treating gynecomastia |
| JPH09508125A (ja) * | 1994-01-21 | 1997-08-19 | セプラコー，インコーポレイテッド | 光学的純正ｒ−（−）−カソデックスを使用した男性ホルモン依存疾患治療のための方法と組成 |
| GB9707800D0 (en) * | 1996-05-06 | 1997-06-04 | Zeneca Ltd | Chemical compounds |
| US6139875A (en) * | 1998-09-29 | 2000-10-31 | Eastman Chemical Company | Aqueous enteric coating composition and low gastric permeability enteric coating |
-
2001
- 2001-11-16 SE SE0103839A patent/SE0103839D0/sv unknown
-
2002
- 2002-10-31 TW TW091132270A patent/TW200406200A/zh unknown
- 2002-11-13 UY UY27539A patent/UY27539A1/es not_active Application Discontinuation
- 2002-11-14 US US10/495,012 patent/US20050038111A1/en not_active Abandoned
- 2002-11-14 KR KR1020047007359A patent/KR20050044468A/ko not_active Application Discontinuation
- 2002-11-14 DE DE60217390T patent/DE60217390T2/de not_active Expired - Fee Related
- 2002-11-14 ES ES02779684T patent/ES2278063T3/es not_active Expired - Lifetime
- 2002-11-14 AR ARP020104386A patent/AR037390A1/es unknown
- 2002-11-14 BR BR0214135-3A patent/BR0214135A/pt not_active Application Discontinuation
- 2002-11-14 AU AU2002343024A patent/AU2002343024A1/en not_active Abandoned
- 2002-11-14 JP JP2003545287A patent/JP2005514355A/ja not_active Withdrawn
- 2002-11-14 IL IL16190202A patent/IL161902A0/xx unknown
- 2002-11-14 CA CA002466986A patent/CA2466986A1/en not_active Abandoned
- 2002-11-14 WO PCT/GB2002/005159 patent/WO2003043606A1/en active IP Right Grant
- 2002-11-14 EP EP02779684A patent/EP1448168B1/en not_active Expired - Lifetime
- 2002-11-14 CN CNA028272277A patent/CN1615122A/zh active Pending
- 2002-11-14 AT AT02779684T patent/ATE350016T1/de not_active IP Right Cessation
- 2002-11-14 MX MXPA04004591A patent/MXPA04004591A/es unknown
-
2004
- 2004-05-13 ZA ZA200403689A patent/ZA200403689B/en unknown
- 2004-06-15 NO NO20042502A patent/NO20042502L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1448168A1 (en) | 2004-08-25 |
| SE0103839D0 (sv) | 2001-11-16 |
| MXPA04004591A (es) | 2004-08-13 |
| EP1448168B1 (en) | 2007-01-03 |
| DE60217390T2 (de) | 2007-11-15 |
| ATE350016T1 (de) | 2007-01-15 |
| BR0214135A (pt) | 2004-10-13 |
| ES2278063T3 (es) | 2007-08-01 |
| UY27539A1 (es) | 2003-07-31 |
| NO20042502L (no) | 2004-08-09 |
| AR037390A1 (es) | 2004-11-10 |
| TW200406200A (en) | 2004-05-01 |
| JP2005514355A (ja) | 2005-05-19 |
| WO2003043606A1 (en) | 2003-05-30 |
| CN1615122A (zh) | 2005-05-11 |
| KR20050044468A (ko) | 2005-05-12 |
| ZA200403689B (en) | 2006-06-28 |
| DE60217390D1 (de) | 2007-02-15 |
| CA2466986A1 (en) | 2003-05-30 |
| AU2002343024A1 (en) | 2003-06-10 |
| US20050038111A1 (en) | 2005-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0302847A3 (en) | Pharmaceutical formulation comprising bicalutamide | |
| GB0102342D0 (en) | Pharmaceutical formulation | |
| GB0319041D0 (en) | Pharmaceutical Formulations | |
| GB0118689D0 (en) | Pharmaceutical formulation | |
| HK1072200A1 (en) | Pro-micelle pharmaceutical compositions | |
| GB0111597D0 (en) | Pharmaceutical compositions | |
| PL366432A1 (en) | Pharmaceutical formulation | |
| IL161902A0 (en) | Pharmaceutical formulation comprising bicalutamide | |
| GB0121715D0 (en) | Pharmaceutical formulations | |
| GB0103638D0 (en) | Pharmaceutical formulations | |
| GB0120701D0 (en) | Pharmaceutical formulations | |
| IL161306A0 (en) | Pharmaceutical formulation comprising (r)-bicalutamide | |
| GB2380129B (en) | Pharmaceutical formulations | |
| GB0105560D0 (en) | Pharmaceutical formulations | |
| GB0104752D0 (en) | Pharmaceutical compositions | |
| GB0125492D0 (en) | Formulation | |
| GB2382302B (en) | Pharmaceutical compositions | |
| ZA200306383B (en) | Pharmaceutical formulation comprising bicalutamide. | |
| GB0124455D0 (en) | Pharmaceutical formulations | |
| GB2375048B (en) | Formulation | |
| GB2396812B (en) | Formulation | |
| GB0116619D0 (en) | Formulation | |
| GB0128138D0 (en) | Pharmaceutical use | |
| GB0112497D0 (en) | Formulation | |
| GB0124712D0 (en) | Pharmaceutical formulation |